Drive line infection rate reduction by developing a fixation kit

Funding Acknowledgements

Type of funding sources: None.

Introduction

Continuous-flow left ventricular assist device (LVAD) therapy has become a standard therapy for patients suffering from end-stage heart failure. One of the serious adverse events during LVAD support is infection. Infections can trigger thromboembolic events, haemorrhagic cerebrovascular accidents , and are the second most common cause of death. Moreover, LVAD-related infection is the leading cause of re-admission and increases the cost of LVAD therapy considerably. Patients with an infection during LVAD support need a significantly prolonged hospital stay.

Background

Left ventricular assist device implantation is one of the operations that patients need special and distinctive health care, and therefore a specialized medical team has been appointed to examine these patients, but from the time the device is installed, these patients suffer from frequent infections at the drive line exit site, and therefore the responsible team faces a great challenge in combating this infection and reducing the infection rate and complications. One of the biggest problems is that we cannot find the exact type of dressing that is used to care for the exit, With the increase in the number of patients who have an infection in the drive line exit site, the team started to identify the reasons that lead to this, and it was found that failure to the fixation of the drive line is one of the biggest causes of infection, and patients reported that the movement of the drive line causes them severe pain and inflammation, which leads to many difficulties in their mobility and daily activities.

Aim

Reaching the best practice and reducing drive line infection rate by managing drive line fixation while increasing the number of the implanted devices.

Process: The LVAD nursing team started in collecting data related to the drive line infection and some modifications were implemented according to the available resources to be used in the drive line modified fixation technique:

Step 1: Our available adhesive dressings were used, and two small holes were made in the middle of it. Figure 1

Step 2: A small gauze strip was passed through the two holes to be fixed around the drive line. Figure 2

Step 3: Then a surgical blade used to make a whistling hole in the adhesive dressing to exit the drive line from it. Figure 3

Results

Based on:

Auditing charts and data collection it shows significant decrease in infection rates and re-admission related to drive line infection.

Recommendation

Develop new material for education

Videos in Arabic, Follow-up handbook and Posters.

Updating AHC staff with the latest driveline wound care protocol

Training sessions, Case study and Simulation lab.

Severe isolated mitral stenosis: are we facing different phenotypes?

Funding Acknowledgements

Type of funding sources: None.

Introduction

Rheumatic mitral valve stenosis (MS) causes progressive left atrial (LA) fibrosis and functional impairment, pulmonary artery systolic hypertension and right ventricular (RV) dysfunction.

Purpose

The aim of the study was the evaluate the different characteristics between high gradients (HG) and low gradient (LG) MS and, within the LG group those with high (LG-HF) or low flow (LG-LF). Moreover, we wanted to evaluate if there was any difference in overall complications and atrial fibrillation (AF) incidence.

Methods

A total of 147 patients with isolated severe MS were retrospectively enrolled from the institutional echo database.  Echocardiograms were read offline and clinical information were obtained from patients` records. Patients were divided into a group with HG (31 patients, mean MS gradient > 10 mmHg) and LG (116 patients, mean MS gradient ≤ 10 mmHg). The group of LG was then divided in low flow (Stroke volume index (SVi) ≤ 35 ml/m2, LF-LG: 68 patients) and in high flow (SVi > 35 ml/m2, HF-LG: 48 patients).

Results

The HG group was younger, although the difference did not reach statistical significance, higher percent of males (45% M vs 22% F, p = 0.02), higher heart rate (HR), left atrial volume, higher tricuspid regurgitation velocity (TVR) and derived pulmonary artery systolic pressure (PASP), RV fractional area changes (RV FAC) but similar RV longitudinal contraction. Moreover, the HG group had more severe MS calculated according to PHT.  The group of LG was divided according to SVi:  LF-LG group compare to HG-MS had higher percent of females (45% F vs 13% M, p < 0.001), similar AF (43% vs 32%, p = ns) and pre surgical complications (19% vs 16%, p = ns). LF-LG group had smaller LA systolic volume (117 ± 51 51 ml vs 148.6 ± 38 ml, p < 0.0001), lower LV-S` (5.3 ± 1.4 vs 6 ± 1.6 cm/s, p = 0.004), lower TRV (2.47 ± 0.5 vs 3.24 ± 0.7 m/s, p < 0.0001), higher TAPSE/PASP (0.64 ± 0.3  vs 0.45 ± 0.29, p < 0.001), lower RV S` (9.79 ± 2.01m/s vs 11.25 ± 3.1 m/s, p = 0.01), higher RVFAC (38.5 ± 9.6% vs 30.9 ± 9.2%, p = 0.0005). The group of LG-LF had also less severe MS (1.3 ± 0.6 cm2 vs 1.15 ± 0.3 cm2, p < 0.01).

Conclusion

Patients with HG MS were those with worst left ventricular involvement, higher PASP and lower RV function. The LF-LG MS were older, and more females were included and even though they had smaller LA, lower values of PASP they had significantly higher percent of AF and similar pre surgical complications.  It could be speculated that LF-LG severe MS patients could be a different phenotype of the disease.

Stuck mechanical valve complication in non-COVID-19 patients during COVID-19 pandemic: single center experience

Funding Acknowledgements

Type of funding sources: None.

Background

Stuck valve is a very rare and severe complication that occurs in mechanical valve replacement patients with ineffective anticoagulation. However, with COVID-19 restriction measures, it became challenging to regularly assess INR to make sure it falls within the target therapeutic range to prevent this complication.

Purpose

We wanted to explore how did the COVID-19 pandemic restrictions impacted mechanical valve replacement patients on chronic anticoagulation and the long-term consequences of limiting their access to health service.

Methods

We present a series of 10 patients on warfarin anticoagulation therapy who either underwent transthoracic echocardiography for a suspected stuck valve or were seen at the outpatient valve clinic with the residual consequences of a stuck valve during the COVID-19 restriction measures in our institute.

Results

Eight patients were female, two of whom were pregnant at the first trimester and eventually went on to receive an abortion; six patients received urgent valve replacement cardiac surgery; four patients were managed medically e.g. with heparin; none had thrombolytic therapy. Stuck prosthetic valves incident has increased significantly during this period, particularly those in the mitral position for which urgent replacement and prolonged hospitalization including intensive care admission, with high in-hospital mortality rates and high costs were necessary. Mean hospital admission time was 27.5 ± 18.5 days.  The cost of treatment, as average estimated reimbursement, was 11,000 USD for medical admission only, and 43,200 USD when surgery was required, up to 64,000 USD when ECMO was part of patient management.

Conclusion

Despite governments’ efforts to implement telemedicine and virtual clinics, COVID-19 restrictions and health-messaging affected the routine follow-up of non-COVID-19 patients. We report dramatic consequences to this drastic change in healthcare: clinical complications, lost lives and inflated healthcare costs in patients with a prosthetic valve. We believe that non-COVID-19 patients have paid, and will continue to pay in the future, a price that is much greater than those patients who have suffered from COVID-19. Active engagement of patients should be implemented in a time of emergencies, and further studies should address the efficacy and cost-effectiveness of public policies aimed to decrease the burden of avoidable complications and missed diagnoses. Abstract Figure. Fluoroscopy in a 70 years old patient

STUDY OF KCNJ11 GENE MUTATIONS IN ASSOCIATION WITH MONOGENIC DIABETES OF INFANCY AND RESPONSE TO SULFONYLUREA TREATMENT IN A COHORT STUDY IN EGYPT

Introduction

KCNJ11 gene activating mutations play a major role in the development of neonatal diabetes mellitus (NDM). KCNJ 11 gene encodes the Kir 6.2 subunit of ATP- sensitive potassium channel which is a critical regulator of pancreatic beta-cell insulin secretion.

Aim

To study KCNJ11 gene mutations in infants with NDM and the effect of sulfonylurea treatment on the glycemic control in patients with KCNJ11 gene mutation.

Subjects and methods

Thirty infants with NDM were screened for KCNJ11 gene mutations by DNA sequencing, insulin therapy was replaced by sulfonylurea treatment in patients with mutations.

Results

R201C heterozygous mutation was found in one patient who was successfully shifted from insulin therapy to sulfonylurea treatment, while E23k, I337V, and S385C polymorphisms were detected in 14 patients.

Conclusion

Screening for KCNJ 11 gene mutations could lead to identification of patients with mutations who can be successfully shifted from insulin therapy to sulfonylurea treatment improving their quality of life.

Role of the physician in bereavement

The purpose of this article is to set forth a clear and concise guide for physicians to use in their treatment of the bereaved. The physician's attitudes toward death and dying, as well as normal and abnormal grief reactions, are reviewed. The role of the physician prior to the time of death, at the time of death, and after the death are discussed. Models of hospital-based programs that can be of significant help to physicians in treating the bereaved are presented also.